nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—AKR1C3—Doxorubicin—testicular cancer	0.278	0.369	CbGbCtD
Mefenamic acid—PTGS1—Ifosfamide—testicular cancer	0.117	0.155	CbGbCtD
Mefenamic acid—CYP2C8—Ifosfamide—testicular cancer	0.0674	0.0895	CbGbCtD
Mefenamic acid—PTGS2—Cisplatin—testicular cancer	0.0673	0.0893	CbGbCtD
Mefenamic acid—PTGS2—Etoposide—testicular cancer	0.0661	0.0877	CbGbCtD
Mefenamic acid—PTGS1—Etoposide—testicular cancer	0.0558	0.0741	CbGbCtD
Mefenamic acid—CYP2C9—Ifosfamide—testicular cancer	0.047	0.0624	CbGbCtD
Mefenamic acid—CYP2C8—Etoposide—testicular cancer	0.0322	0.0428	CbGbCtD
Mefenamic acid—CYP2C9—Cisplatin—testicular cancer	0.0229	0.0304	CbGbCtD
Mefenamic acid—AKR1C3—Podofilox—Etoposide—testicular cancer	0.00357	0.539	CbGdCrCtD
Mefenamic acid—AKR1C3—Vincristine—Vinblastine—testicular cancer	0.00305	0.461	CbGdCrCtD
Mefenamic acid—AKR1C2—testis—testicular cancer	0.00178	0.223	CbGeAlD
Mefenamic acid—AKR1C2—lymph node—testicular cancer	0.00129	0.161	CbGeAlD
Mefenamic acid—AKR1C3—seminal vesicle—testicular cancer	0.00106	0.133	CbGeAlD
Mefenamic acid—AKR1C3—female gonad—testicular cancer	0.000625	0.0784	CbGeAlD
Mefenamic acid—AKR1C3—testis—testicular cancer	0.000554	0.0695	CbGeAlD
Mefenamic acid—AKR1C3—lymph node—testicular cancer	0.000402	0.0504	CbGeAlD
Mefenamic acid—PTGS2—embryo—testicular cancer	0.000383	0.0481	CbGeAlD
Mefenamic acid—PTGS1—seminal vesicle—testicular cancer	0.000377	0.0472	CbGeAlD
Mefenamic acid—PTGS2—seminal vesicle—testicular cancer	0.00036	0.0451	CbGeAlD
Mefenamic acid—Diarrhoea—Dactinomycin—testicular cancer	0.000243	0.00105	CcSEcCtD
Mefenamic acid—Pneumonia—Methotrexate—testicular cancer	0.000243	0.00105	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000242	0.00104	CcSEcCtD
Mefenamic acid—Vomiting—Bleomycin—testicular cancer	0.000242	0.00104	CcSEcCtD
Mefenamic acid—CYP2C8—testis—testicular cancer	0.000242	0.0303	CbGeAlD
Mefenamic acid—Drowsiness—Methotrexate—testicular cancer	0.000241	0.00104	CcSEcCtD
Mefenamic acid—Pancytopenia—Epirubicin—testicular cancer	0.00024	0.00104	CcSEcCtD
Mefenamic acid—Hypotension—Etoposide—testicular cancer	0.00024	0.00103	CcSEcCtD
Mefenamic acid—Rash—Bleomycin—testicular cancer	0.00024	0.00103	CcSEcCtD
Mefenamic acid—Gastritis—Doxorubicin—testicular cancer	0.00024	0.00103	CcSEcCtD
Mefenamic acid—Dermatitis—Bleomycin—testicular cancer	0.00024	0.00103	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000239	0.00103	CcSEcCtD
Mefenamic acid—Renal failure—Methotrexate—testicular cancer	0.000237	0.00102	CcSEcCtD
Mefenamic acid—Dysuria—Epirubicin—testicular cancer	0.000237	0.00102	CcSEcCtD
Mefenamic acid—Stomatitis—Methotrexate—testicular cancer	0.000235	0.00101	CcSEcCtD
Mefenamic acid—Conjunctivitis—Methotrexate—testicular cancer	0.000235	0.00101	CcSEcCtD
Mefenamic acid—Asthma—Doxorubicin—testicular cancer	0.000234	0.00101	CcSEcCtD
Mefenamic acid—Asthenia—Ifosfamide—testicular cancer	0.000233	0.00101	CcSEcCtD
Mefenamic acid—Eosinophilia—Doxorubicin—testicular cancer	0.000232	0.001	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Epirubicin—testicular cancer	0.000231	0.000996	CcSEcCtD
Mefenamic acid—Feeling abnormal—Cisplatin—testicular cancer	0.000231	0.000996	CcSEcCtD
Mefenamic acid—Paraesthesia—Etoposide—testicular cancer	0.000231	0.000994	CcSEcCtD
Mefenamic acid—Pruritus—Ifosfamide—testicular cancer	0.00023	0.000992	CcSEcCtD
Mefenamic acid—Haematuria—Methotrexate—testicular cancer	0.00023	0.000991	CcSEcCtD
Mefenamic acid—Pancreatitis—Doxorubicin—testicular cancer	0.00023	0.00099	CcSEcCtD
Mefenamic acid—Dyspnoea—Etoposide—testicular cancer	0.000229	0.000987	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Epirubicin—testicular cancer	0.000228	0.000985	CcSEcCtD
Mefenamic acid—Somnolence—Etoposide—testicular cancer	0.000228	0.000984	CcSEcCtD
Mefenamic acid—Pneumonia—Epirubicin—testicular cancer	0.000227	0.000979	CcSEcCtD
Mefenamic acid—Nausea—Bleomycin—testicular cancer	0.000226	0.000974	CcSEcCtD
Mefenamic acid—Drowsiness—Epirubicin—testicular cancer	0.000226	0.000973	CcSEcCtD
Mefenamic acid—Vomiting—Dactinomycin—testicular cancer	0.000226	0.000973	CcSEcCtD
Mefenamic acid—Agranulocytosis—Methotrexate—testicular cancer	0.000225	0.00097	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000224	0.000965	CcSEcCtD
Mefenamic acid—Rash—Dactinomycin—testicular cancer	0.000224	0.000965	CcSEcCtD
Mefenamic acid—Decreased appetite—Etoposide—testicular cancer	0.000223	0.000962	CcSEcCtD
Mefenamic acid—Diarrhoea—Ifosfamide—testicular cancer	0.000223	0.000959	CcSEcCtD
Mefenamic acid—Pancytopenia—Doxorubicin—testicular cancer	0.000223	0.000959	CcSEcCtD
Mefenamic acid—Renal failure—Epirubicin—testicular cancer	0.000222	0.000957	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Etoposide—testicular cancer	0.000222	0.000956	CcSEcCtD
Mefenamic acid—Body temperature increased—Cisplatin—testicular cancer	0.000222	0.000955	CcSEcCtD
Mefenamic acid—PTGS1—female gonad—testicular cancer	0.000221	0.0277	CbGeAlD
Mefenamic acid—Jaundice—Epirubicin—testicular cancer	0.00022	0.000949	CcSEcCtD
Mefenamic acid—Stomatitis—Epirubicin—testicular cancer	0.00022	0.000949	CcSEcCtD
Mefenamic acid—Constipation—Etoposide—testicular cancer	0.00022	0.000947	CcSEcCtD
Mefenamic acid—Conjunctivitis—Epirubicin—testicular cancer	0.000219	0.000946	CcSEcCtD
Mefenamic acid—Dysuria—Doxorubicin—testicular cancer	0.000219	0.000944	CcSEcCtD
Mefenamic acid—Haemoglobin—Methotrexate—testicular cancer	0.000218	0.000938	CcSEcCtD
Mefenamic acid—Hepatitis—Methotrexate—testicular cancer	0.000217	0.000933	CcSEcCtD
Mefenamic acid—Haemorrhage—Methotrexate—testicular cancer	0.000217	0.000933	CcSEcCtD
Mefenamic acid—Haematuria—Epirubicin—testicular cancer	0.000215	0.000928	CcSEcCtD
Mefenamic acid—Dizziness—Ifosfamide—testicular cancer	0.000215	0.000927	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Methotrexate—testicular cancer	0.000214	0.000922	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000214	0.000922	CcSEcCtD
Mefenamic acid—Urethral disorder—Methotrexate—testicular cancer	0.000212	0.000915	CcSEcCtD
Mefenamic acid—Feeling abnormal—Etoposide—testicular cancer	0.000212	0.000912	CcSEcCtD
Mefenamic acid—PTGS2—female gonad—testicular cancer	0.000211	0.0265	CbGeAlD
Mefenamic acid—Hyperglycaemia—Doxorubicin—testicular cancer	0.000211	0.000911	CcSEcCtD
Mefenamic acid—Nausea—Dactinomycin—testicular cancer	0.000211	0.000909	CcSEcCtD
Mefenamic acid—Agranulocytosis—Epirubicin—testicular cancer	0.000211	0.000908	CcSEcCtD
Mefenamic acid—Pneumonia—Doxorubicin—testicular cancer	0.00021	0.000906	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Etoposide—testicular cancer	0.00021	0.000905	CcSEcCtD
Mefenamic acid—Drowsiness—Doxorubicin—testicular cancer	0.000209	0.0009	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000207	0.000893	CcSEcCtD
Mefenamic acid—Vomiting—Ifosfamide—testicular cancer	0.000207	0.000891	CcSEcCtD
Mefenamic acid—Renal failure—Doxorubicin—testicular cancer	0.000205	0.000885	CcSEcCtD
Mefenamic acid—Rash—Ifosfamide—testicular cancer	0.000205	0.000884	CcSEcCtD
Mefenamic acid—Dermatitis—Ifosfamide—testicular cancer	0.000205	0.000883	CcSEcCtD
Mefenamic acid—Erythema multiforme—Methotrexate—testicular cancer	0.000205	0.000883	CcSEcCtD
Mefenamic acid—Urticaria—Etoposide—testicular cancer	0.000204	0.00088	CcSEcCtD
Mefenamic acid—Haemoglobin—Epirubicin—testicular cancer	0.000204	0.000878	CcSEcCtD
Mefenamic acid—Jaundice—Doxorubicin—testicular cancer	0.000204	0.000878	CcSEcCtD
Mefenamic acid—Stomatitis—Doxorubicin—testicular cancer	0.000204	0.000878	CcSEcCtD
Mefenamic acid—Abdominal pain—Etoposide—testicular cancer	0.000203	0.000875	CcSEcCtD
Mefenamic acid—Body temperature increased—Etoposide—testicular cancer	0.000203	0.000875	CcSEcCtD
Mefenamic acid—Conjunctivitis—Doxorubicin—testicular cancer	0.000203	0.000875	CcSEcCtD
Mefenamic acid—Hepatitis—Epirubicin—testicular cancer	0.000203	0.000874	CcSEcCtD
Mefenamic acid—Haemorrhage—Epirubicin—testicular cancer	0.000203	0.000874	CcSEcCtD
Mefenamic acid—Tinnitus—Methotrexate—testicular cancer	0.000202	0.00087	CcSEcCtD
Mefenamic acid—Asthenia—Cisplatin—testicular cancer	0.000201	0.000867	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Epirubicin—testicular cancer	0.0002	0.000863	CcSEcCtD
Mefenamic acid—Haematuria—Doxorubicin—testicular cancer	0.000199	0.000859	CcSEcCtD
Mefenamic acid—Urethral disorder—Epirubicin—testicular cancer	0.000199	0.000856	CcSEcCtD
Mefenamic acid—PTGS1—testis—testicular cancer	0.000196	0.0246	CbGeAlD
Mefenamic acid—Agranulocytosis—Doxorubicin—testicular cancer	0.000195	0.00084	CcSEcCtD
Mefenamic acid—Nausea—Ifosfamide—testicular cancer	0.000193	0.000833	CcSEcCtD
Mefenamic acid—Diarrhoea—Cisplatin—testicular cancer	0.000192	0.000827	CcSEcCtD
Mefenamic acid—Erythema multiforme—Epirubicin—testicular cancer	0.000192	0.000826	CcSEcCtD
Mefenamic acid—Alopecia—Methotrexate—testicular cancer	0.000191	0.000825	CcSEcCtD
Mefenamic acid—Mental disorder—Methotrexate—testicular cancer	0.00019	0.000818	CcSEcCtD
Mefenamic acid—Tinnitus—Epirubicin—testicular cancer	0.000189	0.000815	CcSEcCtD
Mefenamic acid—Haemoglobin—Doxorubicin—testicular cancer	0.000188	0.000812	CcSEcCtD
Mefenamic acid—Haemorrhage—Doxorubicin—testicular cancer	0.000188	0.000808	CcSEcCtD
Mefenamic acid—Hepatitis—Doxorubicin—testicular cancer	0.000188	0.000808	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Doxorubicin—testicular cancer	0.000185	0.000798	CcSEcCtD
Mefenamic acid—Asthenia—Etoposide—testicular cancer	0.000184	0.000794	CcSEcCtD
Mefenamic acid—Urethral disorder—Doxorubicin—testicular cancer	0.000184	0.000792	CcSEcCtD
Mefenamic acid—Pruritus—Etoposide—testicular cancer	0.000182	0.000783	CcSEcCtD
Mefenamic acid—Arrhythmia—Epirubicin—testicular cancer	0.000181	0.00078	CcSEcCtD
Mefenamic acid—Alopecia—Epirubicin—testicular cancer	0.000179	0.000772	CcSEcCtD
Mefenamic acid—Vomiting—Cisplatin—testicular cancer	0.000178	0.000768	CcSEcCtD
Mefenamic acid—Vision blurred—Methotrexate—testicular cancer	0.000178	0.000766	CcSEcCtD
Mefenamic acid—Mental disorder—Epirubicin—testicular cancer	0.000178	0.000765	CcSEcCtD
Mefenamic acid—Erythema multiforme—Doxorubicin—testicular cancer	0.000177	0.000764	CcSEcCtD
Mefenamic acid—Rash—Cisplatin—testicular cancer	0.000177	0.000762	CcSEcCtD
Mefenamic acid—Dermatitis—Cisplatin—testicular cancer	0.000177	0.000761	CcSEcCtD
Mefenamic acid—Diarrhoea—Etoposide—testicular cancer	0.000176	0.000758	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Methotrexate—testicular cancer	0.000175	0.000754	CcSEcCtD
Mefenamic acid—Tinnitus—Doxorubicin—testicular cancer	0.000175	0.000754	CcSEcCtD
Mefenamic acid—Anaemia—Methotrexate—testicular cancer	0.000174	0.000751	CcSEcCtD
Mefenamic acid—Flatulence—Epirubicin—testicular cancer	0.000174	0.000749	CcSEcCtD
Mefenamic acid—Tension—Epirubicin—testicular cancer	0.000173	0.000746	CcSEcCtD
Mefenamic acid—Nervousness—Epirubicin—testicular cancer	0.000171	0.000739	CcSEcCtD
Mefenamic acid—Malaise—Methotrexate—testicular cancer	0.00017	0.000733	CcSEcCtD
Mefenamic acid—Dizziness—Etoposide—testicular cancer	0.00017	0.000732	CcSEcCtD
Mefenamic acid—Vertigo—Methotrexate—testicular cancer	0.000169	0.00073	CcSEcCtD
Mefenamic acid—Leukopenia—Methotrexate—testicular cancer	0.000169	0.000727	CcSEcCtD
Mefenamic acid—Arrhythmia—Doxorubicin—testicular cancer	0.000168	0.000722	CcSEcCtD
Mefenamic acid—Nausea—Cisplatin—testicular cancer	0.000167	0.000718	CcSEcCtD
Mefenamic acid—Vision blurred—Epirubicin—testicular cancer	0.000166	0.000717	CcSEcCtD
Mefenamic acid—Alopecia—Doxorubicin—testicular cancer	0.000166	0.000714	CcSEcCtD
Mefenamic acid—Mental disorder—Doxorubicin—testicular cancer	0.000164	0.000708	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Epirubicin—testicular cancer	0.000164	0.000706	CcSEcCtD
Mefenamic acid—Convulsion—Methotrexate—testicular cancer	0.000163	0.000704	CcSEcCtD
Mefenamic acid—Vomiting—Etoposide—testicular cancer	0.000163	0.000704	CcSEcCtD
Mefenamic acid—Anaemia—Epirubicin—testicular cancer	0.000163	0.000703	CcSEcCtD
Mefenamic acid—Rash—Etoposide—testicular cancer	0.000162	0.000698	CcSEcCtD
Mefenamic acid—Dermatitis—Etoposide—testicular cancer	0.000162	0.000697	CcSEcCtD
Mefenamic acid—Headache—Etoposide—testicular cancer	0.000161	0.000694	CcSEcCtD
Mefenamic acid—Flatulence—Doxorubicin—testicular cancer	0.000161	0.000693	CcSEcCtD
Mefenamic acid—Tension—Doxorubicin—testicular cancer	0.00016	0.00069	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000159	0.000687	CcSEcCtD
Mefenamic acid—Malaise—Epirubicin—testicular cancer	0.000159	0.000686	CcSEcCtD
Mefenamic acid—Discomfort—Methotrexate—testicular cancer	0.000159	0.000684	CcSEcCtD
Mefenamic acid—Nervousness—Doxorubicin—testicular cancer	0.000159	0.000683	CcSEcCtD
Mefenamic acid—Vertigo—Epirubicin—testicular cancer	0.000159	0.000683	CcSEcCtD
Mefenamic acid—Syncope—Epirubicin—testicular cancer	0.000158	0.000682	CcSEcCtD
Mefenamic acid—Leukopenia—Epirubicin—testicular cancer	0.000158	0.000681	CcSEcCtD
Mefenamic acid—Palpitations—Epirubicin—testicular cancer	0.000156	0.000672	CcSEcCtD
Mefenamic acid—Confusional state—Methotrexate—testicular cancer	0.000155	0.000669	CcSEcCtD
Mefenamic acid—Loss of consciousness—Epirubicin—testicular cancer	0.000155	0.000668	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methotrexate—testicular cancer	0.000154	0.000663	CcSEcCtD
Mefenamic acid—Vision blurred—Doxorubicin—testicular cancer	0.000154	0.000663	CcSEcCtD
Mefenamic acid—Convulsion—Epirubicin—testicular cancer	0.000153	0.000659	CcSEcCtD
Mefenamic acid—Infection—Methotrexate—testicular cancer	0.000153	0.000659	CcSEcCtD
Mefenamic acid—Nausea—Etoposide—testicular cancer	0.000153	0.000658	CcSEcCtD
Mefenamic acid—Hypertension—Epirubicin—testicular cancer	0.000152	0.000657	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Doxorubicin—testicular cancer	0.000151	0.000653	CcSEcCtD
Mefenamic acid—Anaemia—Doxorubicin—testicular cancer	0.000151	0.00065	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Methotrexate—testicular cancer	0.000151	0.000649	CcSEcCtD
Mefenamic acid—Anxiety—Epirubicin—testicular cancer	0.00015	0.000645	CcSEcCtD
Mefenamic acid—Skin disorder—Methotrexate—testicular cancer	0.000149	0.000644	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000149	0.000643	CcSEcCtD
Mefenamic acid—Discomfort—Epirubicin—testicular cancer	0.000148	0.00064	CcSEcCtD
Mefenamic acid—Malaise—Doxorubicin—testicular cancer	0.000147	0.000635	CcSEcCtD
Mefenamic acid—Dry mouth—Epirubicin—testicular cancer	0.000147	0.000633	CcSEcCtD
Mefenamic acid—Vertigo—Doxorubicin—testicular cancer	0.000147	0.000632	CcSEcCtD
Mefenamic acid—Anorexia—Methotrexate—testicular cancer	0.000147	0.000632	CcSEcCtD
Mefenamic acid—Syncope—Doxorubicin—testicular cancer	0.000146	0.000631	CcSEcCtD
Mefenamic acid—Leukopenia—Doxorubicin—testicular cancer	0.000146	0.00063	CcSEcCtD
Mefenamic acid—Confusional state—Epirubicin—testicular cancer	0.000145	0.000626	CcSEcCtD
Mefenamic acid—Palpitations—Doxorubicin—testicular cancer	0.000144	0.000622	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Epirubicin—testicular cancer	0.000144	0.000621	CcSEcCtD
Mefenamic acid—Oedema—Epirubicin—testicular cancer	0.000144	0.000621	CcSEcCtD
Mefenamic acid—Hypotension—Methotrexate—testicular cancer	0.000144	0.00062	CcSEcCtD
Mefenamic acid—Loss of consciousness—Doxorubicin—testicular cancer	0.000143	0.000618	CcSEcCtD
Mefenamic acid—Infection—Epirubicin—testicular cancer	0.000143	0.000617	CcSEcCtD
Mefenamic acid—PTGS1—lymph node—testicular cancer	0.000142	0.0178	CbGeAlD
Mefenamic acid—Shock—Epirubicin—testicular cancer	0.000142	0.000611	CcSEcCtD
Mefenamic acid—Convulsion—Doxorubicin—testicular cancer	0.000141	0.00061	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Epirubicin—testicular cancer	0.000141	0.000608	CcSEcCtD
Mefenamic acid—Hypertension—Doxorubicin—testicular cancer	0.000141	0.000608	CcSEcCtD
Mefenamic acid—Tachycardia—Epirubicin—testicular cancer	0.000141	0.000606	CcSEcCtD
Mefenamic acid—Skin disorder—Epirubicin—testicular cancer	0.00014	0.000603	CcSEcCtD
Mefenamic acid—Insomnia—Methotrexate—testicular cancer	0.000139	0.0006	CcSEcCtD
Mefenamic acid—Anxiety—Doxorubicin—testicular cancer	0.000139	0.000597	CcSEcCtD
Mefenamic acid—Paraesthesia—Methotrexate—testicular cancer	0.000138	0.000596	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000138	0.000595	CcSEcCtD
Mefenamic acid—Discomfort—Doxorubicin—testicular cancer	0.000137	0.000592	CcSEcCtD
Mefenamic acid—Anorexia—Epirubicin—testicular cancer	0.000137	0.000592	CcSEcCtD
Mefenamic acid—Dyspnoea—Methotrexate—testicular cancer	0.000137	0.000591	CcSEcCtD
Mefenamic acid—Somnolence—Methotrexate—testicular cancer	0.000137	0.00059	CcSEcCtD
Mefenamic acid—Dry mouth—Doxorubicin—testicular cancer	0.000136	0.000586	CcSEcCtD
Mefenamic acid—PTGS2—lymph node—testicular cancer	0.000136	0.017	CbGeAlD
Mefenamic acid—Dyspepsia—Methotrexate—testicular cancer	0.000135	0.000584	CcSEcCtD
Mefenamic acid—Hypotension—Epirubicin—testicular cancer	0.000135	0.00058	CcSEcCtD
Mefenamic acid—Confusional state—Doxorubicin—testicular cancer	0.000134	0.000579	CcSEcCtD
Mefenamic acid—Decreased appetite—Methotrexate—testicular cancer	0.000134	0.000577	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Doxorubicin—testicular cancer	0.000133	0.000574	CcSEcCtD
Mefenamic acid—Oedema—Doxorubicin—testicular cancer	0.000133	0.000574	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000133	0.000573	CcSEcCtD
Mefenamic acid—Infection—Doxorubicin—testicular cancer	0.000132	0.000571	CcSEcCtD
Mefenamic acid—Shock—Doxorubicin—testicular cancer	0.000131	0.000565	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Doxorubicin—testicular cancer	0.00013	0.000562	CcSEcCtD
Mefenamic acid—Insomnia—Epirubicin—testicular cancer	0.00013	0.000561	CcSEcCtD
Mefenamic acid—Tachycardia—Doxorubicin—testicular cancer	0.00013	0.00056	CcSEcCtD
Mefenamic acid—Skin disorder—Doxorubicin—testicular cancer	0.000129	0.000558	CcSEcCtD
Mefenamic acid—Paraesthesia—Epirubicin—testicular cancer	0.000129	0.000557	CcSEcCtD
Mefenamic acid—Dyspnoea—Epirubicin—testicular cancer	0.000128	0.000553	CcSEcCtD
Mefenamic acid—Somnolence—Epirubicin—testicular cancer	0.000128	0.000552	CcSEcCtD
Mefenamic acid—Anorexia—Doxorubicin—testicular cancer	0.000127	0.000547	CcSEcCtD
Mefenamic acid—Feeling abnormal—Methotrexate—testicular cancer	0.000127	0.000547	CcSEcCtD
Mefenamic acid—Dyspepsia—Epirubicin—testicular cancer	0.000127	0.000546	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methotrexate—testicular cancer	0.000126	0.000542	CcSEcCtD
Mefenamic acid—Decreased appetite—Epirubicin—testicular cancer	0.000125	0.00054	CcSEcCtD
Mefenamic acid—Hypotension—Doxorubicin—testicular cancer	0.000125	0.000537	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000124	0.000536	CcSEcCtD
Mefenamic acid—Constipation—Epirubicin—testicular cancer	0.000123	0.000531	CcSEcCtD
Mefenamic acid—Urticaria—Methotrexate—testicular cancer	0.000122	0.000527	CcSEcCtD
Mefenamic acid—Abdominal pain—Methotrexate—testicular cancer	0.000122	0.000524	CcSEcCtD
Mefenamic acid—Body temperature increased—Methotrexate—testicular cancer	0.000122	0.000524	CcSEcCtD
Mefenamic acid—Insomnia—Doxorubicin—testicular cancer	0.000121	0.000519	CcSEcCtD
Mefenamic acid—Paraesthesia—Doxorubicin—testicular cancer	0.00012	0.000516	CcSEcCtD
Mefenamic acid—Dyspnoea—Doxorubicin—testicular cancer	0.000119	0.000512	CcSEcCtD
Mefenamic acid—Feeling abnormal—Epirubicin—testicular cancer	0.000119	0.000511	CcSEcCtD
Mefenamic acid—Somnolence—Doxorubicin—testicular cancer	0.000118	0.000511	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Epirubicin—testicular cancer	0.000118	0.000508	CcSEcCtD
Mefenamic acid—Dyspepsia—Doxorubicin—testicular cancer	0.000117	0.000506	CcSEcCtD
Mefenamic acid—Decreased appetite—Doxorubicin—testicular cancer	0.000116	0.000499	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000115	0.000496	CcSEcCtD
Mefenamic acid—Urticaria—Epirubicin—testicular cancer	0.000114	0.000493	CcSEcCtD
Mefenamic acid—Constipation—Doxorubicin—testicular cancer	0.000114	0.000491	CcSEcCtD
Mefenamic acid—Body temperature increased—Epirubicin—testicular cancer	0.000114	0.000491	CcSEcCtD
Mefenamic acid—Abdominal pain—Epirubicin—testicular cancer	0.000114	0.000491	CcSEcCtD
Mefenamic acid—Asthenia—Methotrexate—testicular cancer	0.00011	0.000476	CcSEcCtD
Mefenamic acid—Feeling abnormal—Doxorubicin—testicular cancer	0.00011	0.000473	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000109	0.00047	CcSEcCtD
Mefenamic acid—Pruritus—Methotrexate—testicular cancer	0.000109	0.000469	CcSEcCtD
Mefenamic acid—Urticaria—Doxorubicin—testicular cancer	0.000106	0.000456	CcSEcCtD
Mefenamic acid—Abdominal pain—Doxorubicin—testicular cancer	0.000105	0.000454	CcSEcCtD
Mefenamic acid—Body temperature increased—Doxorubicin—testicular cancer	0.000105	0.000454	CcSEcCtD
Mefenamic acid—Diarrhoea—Methotrexate—testicular cancer	0.000105	0.000454	CcSEcCtD
Mefenamic acid—Asthenia—Epirubicin—testicular cancer	0.000103	0.000445	CcSEcCtD
Mefenamic acid—Pruritus—Epirubicin—testicular cancer	0.000102	0.000439	CcSEcCtD
Mefenamic acid—Dizziness—Methotrexate—testicular cancer	0.000102	0.000439	CcSEcCtD
Mefenamic acid—Diarrhoea—Epirubicin—testicular cancer	9.85e-05	0.000425	CcSEcCtD
Mefenamic acid—Vomiting—Methotrexate—testicular cancer	9.78e-05	0.000422	CcSEcCtD
Mefenamic acid—Rash—Methotrexate—testicular cancer	9.7e-05	0.000418	CcSEcCtD
Mefenamic acid—Dermatitis—Methotrexate—testicular cancer	9.69e-05	0.000418	CcSEcCtD
Mefenamic acid—Headache—Methotrexate—testicular cancer	9.64e-05	0.000415	CcSEcCtD
Mefenamic acid—Asthenia—Doxorubicin—testicular cancer	9.56e-05	0.000412	CcSEcCtD
Mefenamic acid—Dizziness—Epirubicin—testicular cancer	9.52e-05	0.00041	CcSEcCtD
Mefenamic acid—Pruritus—Doxorubicin—testicular cancer	9.43e-05	0.000406	CcSEcCtD
Mefenamic acid—Vomiting—Epirubicin—testicular cancer	9.16e-05	0.000395	CcSEcCtD
Mefenamic acid—Nausea—Methotrexate—testicular cancer	9.14e-05	0.000394	CcSEcCtD
Mefenamic acid—Diarrhoea—Doxorubicin—testicular cancer	9.12e-05	0.000393	CcSEcCtD
Mefenamic acid—Rash—Epirubicin—testicular cancer	9.08e-05	0.000391	CcSEcCtD
Mefenamic acid—Dermatitis—Epirubicin—testicular cancer	9.07e-05	0.000391	CcSEcCtD
Mefenamic acid—Headache—Epirubicin—testicular cancer	9.02e-05	0.000389	CcSEcCtD
Mefenamic acid—Dizziness—Doxorubicin—testicular cancer	8.81e-05	0.00038	CcSEcCtD
Mefenamic acid—Nausea—Epirubicin—testicular cancer	8.55e-05	0.000369	CcSEcCtD
Mefenamic acid—Vomiting—Doxorubicin—testicular cancer	8.47e-05	0.000365	CcSEcCtD
Mefenamic acid—Rash—Doxorubicin—testicular cancer	8.4e-05	0.000362	CcSEcCtD
Mefenamic acid—Dermatitis—Doxorubicin—testicular cancer	8.39e-05	0.000362	CcSEcCtD
Mefenamic acid—Headache—Doxorubicin—testicular cancer	8.35e-05	0.00036	CcSEcCtD
Mefenamic acid—Nausea—Doxorubicin—testicular cancer	7.91e-05	0.000341	CcSEcCtD
